ArticlePatient preference and adherence2025
Emotional Suppression Characteristics and Influencing Factors of Ovarian Cancer Patients - Latent Profile Analysis.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Social alienation among people with bladder cancer: A combined structural equation modeling and fuzzy-set qualitative comparative analysis.Asia-Pacific journal of oncology nursing · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This quantitative study aimed to analyze the potential categories of emotional suppression characteristics and explore the influencing factors of different categories among ovarian cancer chemotherapy patients in Western Region of China. Methods: From September 2024 to March 2025, a convenience sampling method was used to administer a questionnaire to ovarian cancer chemotherapy patients at a gynecology center within a university hospital situated in the Northwest region of China. The investigation employed general information questionnaires, the Emotional Inhibition Scale (EIS), Social Constraint Scales (SCS), Family APGAR Index (APGAR), and the Hospital Anxiety and Depression Scale (HADS). Latent profile analysis (LPA) was conducted to identify the profiles of emotional suppression levels in patients with ovarian cancer undergoing chemotherapy. Multinomial logistic regression was used to investigate the correlations among these profiles in ovarian cancer chemotherapy patients. Results: A total of 228 ovarian cancer chemotherapy patients participated, yielding an average score of 26.76 ± 5.71 on the emotional suppression. The LPA identified three emotion suppression profiles: high level emotional inhibition-low verbal inhibition (Profile 1,13.0%), high level emotional inhibition-high verbal inhibition (Profile 2,46.1%) and low level emotional inhibition-medium verbal inhibition (Profile 3,40.8%); Multiple Logistic regression analysis revealed that educational attainment (high/low), anxiety symptoms, severe family dysfunction, disease recurrence (yes), marital status (divorced/widowed), and social constraint were significant contributing factors. Conclusion: Our research findings reveal significant heterogeneity in emotional suppression among ovarian cancer patients, which provides valuable information for tailoring intervention measures to meet individual needs, especially for patients in the high-level emotional inhibition group. To enhance patients' emotional management capabilities and alleviate their levels of emotional inhibition, healthcare practitioners should fully consider how the emotional regulation subgroup is influenced by factors such as disease recurrence, educational background, marital status, anxiety levels, family support and patients' perceived social constraints in the medical environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.